Read + Share
Amedeo Smart
Independent Medical Education
Yu W, Ye F, Yuan X, Ma Y, et al. A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer. BMC Cancer 2021;21:877.PMID: 34332557
Email
LinkedIn
Facebook
Twitter
Privacy Policy